Q2 2017 13F Holdings Report, New Holdings, Stock Holdings
Signature - Title
Joseph Tropeano - Chief Compliance Officer and Chief Operating Officer
Location
New York, NY
Holdings as of
June 30, 2017
Value $
$7.01M
Num holdings
1
Date filed
11/14/2017, 09:34 AM
Description
Request for Confidential Treatment (8/14/2017): Confidential Treatment Expired on 11/14/2017. The Form 13F report requires disclosure of the manager that files the report, the name and class of the security, the CUSIP code, the number of shares as
of the end of the calendar quarter for which the report is filed, and the total market value. The market value
column should not be used as a substitute for Assets Under Management (AUM), as it does not include cash held in
accounts.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
This filing lists securities holdings reported on the form 13F filed on 08-14-2017 pursuant to a request for confidential treatment and for which confidential treatment expired on 11-14-2017.
Person Signing this Report on Behalf of Reporting Manager:
Name
Title
City, State
Date
Michael Panzner
Chief Compliance Officer
New York, New York
11/14/2017
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.